These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 2232938)
41. Interpretation of cancer prevention trials. Moon TE Prev Med; 1989 Sep; 18(5):721-31. PubMed ID: 2694166 [TBL] [Abstract][Full Text] [Related]
42. The scope of nutrition intervention trials with cancer-related endpoints. Chlebowski RT; Grosvenor M Cancer; 1994 Nov; 74(9 Suppl):2734-8. PubMed ID: 7954294 [TBL] [Abstract][Full Text] [Related]
43. Diet and subsequent survival in women with breast cancer. Ingram D Br J Cancer; 1994 Mar; 69(3):592-5. PubMed ID: 8123493 [TBL] [Abstract][Full Text] [Related]
44. Nutrients, vitamins and minerals in cancer prevention: facts and fallacies. Young VR; Richardson DP Cancer; 1979 May; 43(5 Suppl):2125-36. PubMed ID: 376109 [TBL] [Abstract][Full Text] [Related]
45. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials. Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331 [TBL] [Abstract][Full Text] [Related]
46. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials. Greenwald P J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595 [TBL] [Abstract][Full Text] [Related]
47. Natural agents in the prevention of cancer, part two: preclinical data and chemoprevention for common cancers. Lamson DW; Brignall MS Altern Med Rev; 2001 Apr; 6(2):167-87. PubMed ID: 11302780 [TBL] [Abstract][Full Text] [Related]
48. Chemoprevention trials and surrogate end point biomarkers in the cervix. Mitchell MF; Hittelman WK; Lotan R; Nishioka K; Tortolero-Luna G; Richards-Kortum R; Wharton JT; Hong WK Cancer; 1995 Nov; 76(10 Suppl):1956-77. PubMed ID: 8634987 [TBL] [Abstract][Full Text] [Related]
49. Nutrient intakes: cancer causation and prevention. Leonard TK; Mohs ME; Watson RR Prog Food Nutr Sci; 1986; 10(3-4):237-77. PubMed ID: 3295993 [TBL] [Abstract][Full Text] [Related]
51. Creating a new paradigm in nutrition research within the National Cancer Institute. Greenwald P; Milner JA; Clifford CK J Nutr; 2000 Dec; 130(12):3103-5. PubMed ID: 11110877 [TBL] [Abstract][Full Text] [Related]
54. Chemoprevention of cancer: a controversial and instructive story. Vainio H Br Med Bull; 1999; 55(3):593-9. PubMed ID: 10746349 [TBL] [Abstract][Full Text] [Related]
56. Premalignant lesions: role of antioxidant vitamins and beta-carotene in risk reduction and prevention of malignant transformation. Singh VN; Gaby SK Am J Clin Nutr; 1991 Jan; 53(1 Suppl):386S-390S. PubMed ID: 1985417 [TBL] [Abstract][Full Text] [Related]
57. Nutrition and cancer prevention: a multidisciplinary perspective on human trials. Forman MR; Hursting SD; Umar A; Barrett JC Annu Rev Nutr; 2004; 24():223-54. PubMed ID: 15189120 [TBL] [Abstract][Full Text] [Related]
58. Nutritional supplements for people being treated for active tuberculosis. Sinclair D; Abba K; Grobler L; Sudarsanam TD Cochrane Database Syst Rev; 2011 Nov; (11):CD006086. PubMed ID: 22071828 [TBL] [Abstract][Full Text] [Related]
59. Lessons learned from randomized clinical trials of micronutrient supplementation for cancer prevention. Mayne ST; Ferrucci LM; Cartmel B Annu Rev Nutr; 2012 Aug; 32():369-90. PubMed ID: 22524186 [TBL] [Abstract][Full Text] [Related]
60. Cancer and nutritional misconceptions: a perspective. Mogadam M Am J Gastroenterol; 1988 Dec; 83(12):1346-51. PubMed ID: 3057874 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]